Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Aligos Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +7 vs. Q4 2022
- Shares held
- 27.3M
- +787.4K (+3.0%) vs. Q4 2022
- Total value
- $23.9M
- −$1.35M (−5.4%) vs. Q4 2022
- New holders
- 10
- 13 more added
- Sold out
- 3
- 11 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 3,948,360 | $3.45M | 0.11% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,547,030 | $3.10M | 0.23% | 00.0% | Unchanged |
| Tang Capital Management LLC | 3,424,800 | $2.99M | 0.45% | +608,409+21.6% | Added |
| Versant Venture Management, LLC | 2,320,381 | $2.03M | 4.23% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 2,309,764 | $2.02M | 0.04% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,076,400 | $1.81M | 0.01% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,223,278 | $1.07M | 0.00% | −250,000−17.0% | Reduced |
| Bank of America Corp | 1,147,783 | $1.00M | 0.00% | −2,365−0.2% | Reduced |
| Newtyn Management, LLC | 1,021,461 | $892.8K | 0.18% | −478,539−31.9% | Reduced |
| Vanguard Group Inc | 1,016,681 | $888.6K | 0.00% | +3,185+0.3% | Added |
| Logos Global Management LP | 1,000,000 | $874.0K | 0.13% | +1,000,000 | New |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $649.6K | 0.27% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 631,887 | $552.3K | 0.25% | +631,887 | New |
| Acadian Asset Management LLC | 564,715 | $492.0K | 0.00% | +230,011+68.7% | Added |
| Renaissance Technologies LLC | 452,860 | $396.0K | 0.00% | −79,400−14.9% | Reduced |
| Millennium Management LLC | 403,370 | $353.0K | 0.00% | +32,051+8.6% | Added |
| BlackRock Inc. | 307,601 | $268.8K | 0.00% | +1520.0% | Added |
| Geode Capital Management, LLC | 199,858 | $174.7K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 132,724 | $116.0K | 0.00% | +130,371+5,540.6% | Added |
| Marshall Wace, LLP | 108,588 | $94.5K | 0.00% | +108,588 | New |
| State Street Corp | 97,423 | $85.1K | 0.00% | +36,600+60.2% | Added |
| Bridgeway Capital Management, LLC | 92,000 | $80.4K | 0.00% | −20,000−17.9% | Reduced |
| Citadel Advisors LLC | 87,877 | $76.8K | 0.00% | +1,599+1.9% | Added |
| Two Sigma Advisers, LP | 78,200 | $68.3K | 0.00% | −4,300−5.2% | Reduced |
| Deutsche Bank AG | 71,290 | $62.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 56,857 | $49.7K | 0.00% | −33,561−37.1% | Reduced |
| Man Group plc | – | $49.5K | 0.00% | – | New |
| Royal Bank of Canada | 44,715 | $39.0K | 0.00% | +44,697+248,316.7% | Added |
| Northern Trust Corp | 39,351 | $34.4K | 0.00% | +6,747+20.7% | Added |
| Jane Street Group, LLC | 26,249 | $22.9K | 0.00% | +9,829+59.9% | Added |
| HRT Financial LP | 26,273 | $22.0K | 0.00% | −39,986−60.3% | Reduced |
| Susquehanna International Group, LLP | 24,594 | $21.5K | 0.00% | +24,594 | New |
| HarbourVest Partners LLC | 18,783 | $16.4K | 0.01% | 00.0% | Unchanged |
| CWM, LLC | 16,891 | $15.0K | 0.00% | +16,891 | New |
| Cubist Systematic Strategies, LLC | 13,292 | $11.6K | 0.00% | +13,289+442,966.7% | Added |
| Advisor Group Holdings, Inc. | 8,000 | $6.99K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,329 | $2.04K | 0.00% | +2,329 | New |
| Federated Hermes, Inc. | 1,623 | $1.42K | 0.00% | −1,557−49.0% | Reduced |
| JPMorgan Chase & Co | 677 | $1.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,579 | $1.00K | 0.00% | +1,579 | New |
| FMR LLC | 1,000 | $874 | 0.00% | −12−1.2% | Reduced |
| Point72 Asset Management, L.P. | 247 | $216 | 0.00% | −905,649−100.0% | Reduced |
| Wells Fargo & Company | 176 | $154 | 0.00% | +3+1.7% | Added |
| ZRC Wealth Management, LLC | 100 | $88 | 0.00% | +100 | New |
| Newbridge Financial Services Group, Inc. | 37 | $32 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 92 | $0 | 0.00% | +92 | New |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −263,832−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −36,367−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −85−100.0% | Sold out |